Your browser doesn't support javascript.
Early tolerability of Comirnaty vaccine in patients with chronic neurological diseases.
Budowski, C; Zavanone, C; Thivard, L; Vassilev, K; Dupont, S.
  • Budowski C; Rehabilitation Unit, Hôpital de la Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France; Sorbonne Université, Faculté de médecine, 91-105 boulevard de l'hôpital, 75013 Paris, France. Electronic address: clara.budowski@gmail.com.
  • Zavanone C; Rehabilitation Unit, Hôpital de la Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
  • Thivard L; Rehabilitation Unit, Hôpital de la Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
  • Vassilev K; Rehabilitation Unit, Hôpital de la Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
  • Dupont S; Rehabilitation Unit, Hôpital de la Pitié-Salpêtrière, AP-HP, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France; Sorbonne Université, Faculté de médecine, 91-105 boulevard de l'hôpital, 75013 Paris, France; UMPC-UMR 7225 CNRS-UMRS 975 Inserm, Centre de recherche de l'Institut du Cerveau et de
Rev Neurol (Paris) ; 177(10): 1262-1265, 2021 Dec.
Article in English | MEDLINE | ID: covidwho-1466808
ABSTRACT
Patients with chronic neurological diseases may have predisposing risk factors for severe COVID-19 and should be considered as priority candidates for SARS-CoV-2 vaccination. Nevertheless, the safety of RNA vaccine was evaluated in healthy volunteers or in patients with stable chronic medical conditions excluding patients with chronic neurological diseases. We report here the early tolerability of Comirnaty vaccine in 36 patients with chronic neurological diseases and demonstrate good early tolerability, better than found in healthy people in phase 3 trials.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Neurol (Paris) Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Rev Neurol (Paris) Year: 2021 Document Type: Article